Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin.

No abstract is available for this paper.

• Publication year

  1969

• Venue

  Science

• Publication date

  1969-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1097/00007890-196907000-00012PMID 4177430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological enhancement by mouse isoantibodies: the importance of complement fixation.

  1968cited by this paper
• Serum complement in the rejection of sarcoma I ascites tumor grafts.

  1968cited by this paper
• In vivo and in vitro properties of intact and pepsin-digested heterologous anti-mouse thymus antibodies.

  1968cited by this paper
• Characterization of immunologically active substances from canine renal allotransplants.

  1968cited by this paper
• Blocking Activity of Non-cytotoxic F(ab')2 Tumor Cell Antibody Fragments∗

  1968cited by this paper
• Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.

  1968cited by this paper
• Immunochemical identification of cytophilic antibody in human lymphocytes.

  1968cited by this paper
• STUDIES OF HUMAN ANTI-γ-GLOBULIN FACTORS REACTING WITH PEPSIN-DIGESTED γ-GLOBULINS

  1967cited by this paper
• Loss of cytotoxicity of rabbit anti-Ehrlich ascites tumor cell antibody following pepsin digestion.

  1966cited by this paper
• Capacity of Pepsin-digested Antibody to inhibit Antibody Formation

  1966cited by this paper
• Heterogeneity in biologic functions of antibodies: implications for immunologic tumor enhancement.

  1965cited by this paper
• PROPERTIES OF GUINEA PIG 7S ANTIBODIES

  1963cited by this paper
• Studies on the mechanism of immunological enhancement of tumor homografts. III. Interaction between humoral isoantibodies and immune lymphoid cells.

  1963cited by this paper
• Studies on the mechanism of immunological enhancement of tumor homografts. I. Specificity of immunological enhancement.

  1963cited by this paper
• Studies on the mechanism of immunological enhancement of tumor homografts. II. Effect of isoantibodies on various tumor cells.

  1963cited by this paper
• Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

  1960cited by this paper
• Studies on the mechanism of immunological enhancement of tumor grafts.

  1960cited by this paper
• Enzymatic Digestion of Rabbit Globulin.∗

  1959cited by this paper
• Factors determining homograft destruction and immunological enhancement in mice receiving successive tumor inocula.

  1958cited by this paper

• Depressed immunity and the development of cancer.

  1981cites this paper
• Circulating immune complexes as possible cause for anticomplementary activity in humans with malignant melanoma

  1979cites this paper
• Suppressor cells in neoplastic disease.

  1978cites this paper
• The suppressor-cell network in cancer (second of two parts).

  1978cites this paper
• Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity.

  1974cites this paper
• A radioimmunoassay specific for the antigenic determinants exposed by pepsin digestion of human immunoglobulin G.

  1974cites this paper
• RENAL TRANSPLANTATION IN THE INBRED RAT XIX. In Vitro Correlates of Enhancement Induction

  1973cites this paper
• Inhibition of renal allograft rejection. Instances in dogs with specific enchancing immunoglobulin and its proteolytic fragments.

  1973cites this paper
• Specific enhancement of hepatoma growth using methylated bovine serum albumin and pertussis vaccine.

  1972cites this paper
• Immunological enhancement: a study of blocking antibodies.

  1972cites this paper
• Immune response in the hamster. VI. Antibody response in polyoma oncogenesis.

  1972cites this paper
• F(ab') 2 -like immunoglobulin fragments in urines from patients with systemic lupus erythematosus.

  1972cites this paper
• Antitissue versus antimicrobial cellular immunity: a perspective.

  1971cites this paper
• PREPARATION OF SPECIFIC ANTI-ENDOTHELIAL CELL SERUM

  1971cites this paper
• Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

  1971cites this paper
• Passive immunotherapy of leukemia and other cancer.

  1971cites this paper
• The Effect of Antiserum Fractions on Ehrlich Ascites Tumour Cells

  1971cites this paper
• Enhancement of rat renal allografts with F(ab')2 fragment of donor-specific antikidney serum.

  1971cites this paper
• F(ab′)2-like Fragments from Severely Burned Patients provide a New Serum Immunoglobin Component

  1970cites this paper
• RENAL TRANSPLANTATION IN THE INBRED RAT: XIV. Mechanism of the Modified Rejection Produced by Bone Marrow Cell Pretreatment

  1970cites this paper
• Effect of Cell Surface Antigen Density on Immunological Enhancement

  1970cites this paper